Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
Titel:
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
Auteur:
Fedorova, Liudmila V. Lepik, Kirill V. Volkov, Nikita P. Kotselyabina, Polina V. Borzenkova, Evgenia S. Popova, Marina O. Beynarovich, Anastasia V. Baykov, Vadim V. Kozlov, Andrey V. Moiseev, Ivan S. Mikhailova, Natalia B. Kulagin, Alexander D.